Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis | 2023 | Frontiers in Pharmacology |
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis | 2023 | The Cochrane Database of Systematic Reviews |
Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials | 2023 | Hematology/Oncology and Stem Cell Therapy |
Switch Maintenance Therapy for Metastatic Urothelial Carcinoma | 2022 | Bladder Cancer (Amsterdam, Netherlands) |
A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer | 2022 | Medicine |
Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials | 2022 | World Journal of Clinical Oncology |
Comparative Efficacy and Safety of Anti-PD-1/PD-L1 for the Treatment of Non-Small Cell Lung Cancer: A Network Meta-Analysis of 13 Randomized Controlled Studies | 2022 | Frontiers in Oncology |
How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review | 2022 | Frontiers in Oncology |
The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis | 2021 | BMC Cancer |
Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis | 2021 | Cancer Immunology |
The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis | 2020 | Annals of Palliative Medicine |
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder | 2020 | European Urology Oncology |
Targeted therapy for metastatic renal cell carcinoma | 2020 | The Cochrane Database of Systematic Reviews |
Checkpoint inhibitors in advanced nonsmall-cell lung cancer; a Bayesian network meta-analysis | 2020 | Journal of Cancer Research and Therapeutics |
The clinical significance of routine risk categorization in metastatic renal cell carcinoma and its impact on treatment decision-making: a systematic review | 2020 | Future Oncology (London, England) |
Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis | 2020 | Expert Opinion on Drug Safety |
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis | 2020 | Cancers |
Combination Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis | 2020 | American Journal of Clinical Oncology |
The efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma: a meta-analysis of published clinical trials | 2020 | Clinical & Translational Oncology |
The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review | 2019 | Frontiers in Pharmacology |